HIP Fracture Accelerated Surgical TreaTment and Care TracK 2 Trial
Hip Fractures | Myocardial InjuryThe HIP ATTACK-2 trial is a multicentre, international, parallel group randomized controlled trial to determine whether accelerated surgery for hip fracture in patients with acute myocardial injury is superior to standard care in reducing death at 90 days after randomization. The trial will also assess secondary outcomes at 90 days after randomization: inability to independently walk 3 metres, time to first mobilization (first standing and first full weight bear), composite and individual assessment of major complications (e.g., mortality, non-fatal myocardial infarction, acute congestive heart failure, and stroke), delirium, length of stay, pain, and quality of life.
null
Participation Requirements
-
Sex:
ALL -
Eligible Ages:
45 and up
Participation Criteria
Inclusion Criteria:
1. age ≥45 years;
2. diagnosis of hip fracture during working hours with a low-energy mechanism requiring surgery;
3. troponin elevation ( at least one troponin measurement above the upper limit of normal occurring from the time of hip fracture to the time of randomization); and
4. informed consent.
Exclusion Criteria:
1. taking a therapeutic dose of an anticoagulant for which no reversing agent is available and the anesthesiologist or surgeon believe surgery within 6 hours of eligibility criteria met would not be safe;
2. patients on a therapeutic vitamin K antagonist with a history of heparin induced thrombocytopenia (HIT);
3. patients with peri-prosthetic fracture, open fracture or bilateral fractures;
4. patients requiring an emergency surgery for another reason (e.g., subdural hematoma);
5. patients with acute myocardial infarction deemed to be clinically unstable, with a mechanical complication (i.e., acute papillary muscle rupture, ventricular septal defect), ST elevation myocardial infarction, or cardiogenic shock;
6. patients refusing consent; or
7. patients previously enrolled in HIP ATTACK-2.
Study Location
Juravinski Hospital
Juravinski HospitalHamilton, Ontario
Canada
Contact Study Team
Ameen Patel, MD
St. Joseph's Healthcare Hamilton
St. Joseph's Healthcare HamiltonHamilton, Ontario
Canada
Contact Study Team
Flavia Borges, MD
Ottawa General Hospital
Ottawa General HospitalOttawa, Ontario
Canada
Contact Study Team
Robert Feibel, MD
Victoria Hospital
Victoria HospitalLondon, Ontario
Canada
Contact Study Team
Abdel Lawendy, MD
University of Alberta Hospital
University of Alberta HospitalEdmonton, Alberta
Canada
Contact Study Team
Mike Jacka, MD
Markham Stouffville Hospital
Markham Stouffville HospitalMarkham, Ontario
Canada
Contact Study Team
Steve McMahon, MD
- Study Sponsored By
- Population Health Research Institute
- Participants Required
- More Information
- Study ID:
NCT04743765